Skip to main content
Top
Published in: BMC Health Services Research 1/2005

Open Access 01-12-2005 | Research article

Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy

Authors: Marco Cosentino, Emilia Martignoni, Donatella Michielotto, Daniela Calandrella, Giulio Riboldazzi, Claudio Pacchetti, Gianmario Frigo, Giuseppe Nappi, Sergio Lecchini

Published in: BMC Health Services Research | Issue 1/2005

Login to get access

Abstract

Background

Parkinson's disease (PD) is a chronic neurodegenerative disease which at present has no cure, and it usually results in severe disability. The burden of PD increases as the illness progresses, resulting in the extensive utilisation of both health and community services. Knowledge of healthcare use patterns and of their determinants may greatly contribute to improve patient care, however few studies have examined this issue in PD. The present study was devised to describe the type of and reasons for medical healthcare resource use in persons with PD attending a Centre for PD and Movement Disorders, and to examine drug prescriptions issued on such occasions.

Methods

The study was a retrospective, cross-sectional survey in a cohort of ambulatory patients with PD, conducted by means of standard interviews.

Results

In the year before the study, 92 (70.8%) of 130 patients used medical healthcare resources: 1/5 of the patients was admitted to hospital, 1/5 to emergency room, 2/5 were visited by a non-neurology specialist, and 1/4 by the GP. Reasons were: nearly 20% programmed hospital admissions and visits, and more than 25% injuries and musculo-skeletal diseases. Other conditions typically occurring in PD (e.g. dementia, diabetes and cardio- and cerebro-vascular disease) were less frequently involved. On such occasions, drugs for PD were occasionally changed, however drug prescriptions for other indications were issued to more than 66% of the patients.

Conclusion

Several physicians other than the neurologist may take care of PD patients on different occasions, thus emphasising the need for communication between the reference neurologist and other physicians who from time to time may visit the patient.
Literature
1.
go back to reference Olanow CW, Watts RL, Koller WC: An algorithm for the management of Parkinson's disease: treatment guidelines. Neurology. 2001, 56 (Suppl 5): S1-S88.CrossRefPubMed Olanow CW, Watts RL, Koller WC: An algorithm for the management of Parkinson's disease: treatment guidelines. Neurology. 2001, 56 (Suppl 5): S1-S88.CrossRefPubMed
2.
go back to reference Goetz CG, Koller WC, Poewe W, et al: Management of Parkinson's disease: an evidence-based review. Mov Disord. 2002, 17 (Suppl 4): S1-S166. Goetz CG, Koller WC, Poewe W, et al: Management of Parkinson's disease: an evidence-based review. Mov Disord. 2002, 17 (Suppl 4): S1-S166.
3.
go back to reference Bergamasco B, Abbruzzese G, Albanese A, et al: Guidelines for the treatment of Parkinson's Disease 2002. Neurol Sci. 2003, 24 (Suppl 3): S157-S164. Bergamasco B, Abbruzzese G, Albanese A, et al: Guidelines for the treatment of Parkinson's Disease 2002. Neurol Sci. 2003, 24 (Suppl 3): S157-S164.
4.
go back to reference de Rijk MC, Tzourio C, Breteler MM, et al: Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997, 62: 10-15.CrossRefPubMedPubMedCentral de Rijk MC, Tzourio C, Breteler MM, et al: Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997, 62: 10-15.CrossRefPubMedPubMedCentral
5.
go back to reference Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord. 2000, 15: 819-825. 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO;2-P.CrossRefPubMed Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord. 2000, 15: 819-825. 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO;2-P.CrossRefPubMed
6.
go back to reference Singer E: Social costs of Parkinson's disease. J Chronic Dis. 1973, 26: 243-254. 10.1016/0021-9681(73)90105-7.CrossRefPubMed Singer E: Social costs of Parkinson's disease. J Chronic Dis. 1973, 26: 243-254. 10.1016/0021-9681(73)90105-7.CrossRefPubMed
7.
go back to reference Rubinstein LM, Chrischilles EA, Voelker MD: The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Pharmacoeconomics. 1997, 12: 486-498.CrossRef Rubinstein LM, Chrischilles EA, Voelker MD: The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Pharmacoeconomics. 1997, 12: 486-498.CrossRef
8.
go back to reference Parashos SA, Maraganore DM, O'Brien PC, Rocca WA: Medical services utilization and prognosis in Parkinson's disease: a population-based study. Mayo Clin Proc. 2002, 77: 918-925.CrossRefPubMed Parashos SA, Maraganore DM, O'Brien PC, Rocca WA: Medical services utilization and prognosis in Parkinson's disease: a population-based study. Mayo Clin Proc. 2002, 77: 918-925.CrossRefPubMed
9.
go back to reference Van den Eeeden SK, Nelson LM, Tanner CM: First year resource utilization among Parkinson's disease patients and matched controls in a managed care setting. Neurology. 1998, 50: A374.CrossRef Van den Eeeden SK, Nelson LM, Tanner CM: First year resource utilization among Parkinson's disease patients and matched controls in a managed care setting. Neurology. 1998, 50: A374.CrossRef
10.
go back to reference Hagell P, Nordling S, Reimer J, Grabowski M, Persson U: Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov Disord. 2002, 17: 1213-1220. 10.1002/mds.10262.CrossRefPubMed Hagell P, Nordling S, Reimer J, Grabowski M, Persson U: Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov Disord. 2002, 17: 1213-1220. 10.1002/mds.10262.CrossRefPubMed
11.
go back to reference Pressley JC, Louis ED, Tang M-X, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology. 2003, 60: 87-93. 10.1159/000074508.CrossRefPubMed Pressley JC, Louis ED, Tang M-X, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology. 2003, 60: 87-93. 10.1159/000074508.CrossRefPubMed
12.
go back to reference Dodel RC, Berger K, Oertel WH: Health related quality of life and healthcare utilisation in patients with Parkinson's disease. Impact of motor fluctuations and dyskinesias. Pharmacoeconomics. 2001, 19: 1013-1038.CrossRefPubMed Dodel RC, Berger K, Oertel WH: Health related quality of life and healthcare utilisation in patients with Parkinson's disease. Impact of motor fluctuations and dyskinesias. Pharmacoeconomics. 2001, 19: 1013-1038.CrossRefPubMed
13.
go back to reference de Boer AGEM, Sprangers MAG, Speelman HD, de Haes HCJM: Predictors of health care use in patients with Parkinson's disease: a longitudinal study. Mov Disord. 1999, 14: 772-779. 10.1002/1531-8257(199909)14:5<772::AID-MDS1009>3.0.CO;2-S.CrossRefPubMed de Boer AGEM, Sprangers MAG, Speelman HD, de Haes HCJM: Predictors of health care use in patients with Parkinson's disease: a longitudinal study. Mov Disord. 1999, 14: 772-779. 10.1002/1531-8257(199909)14:5<772::AID-MDS1009>3.0.CO;2-S.CrossRefPubMed
14.
go back to reference Leoni O, Martignoni E, Cosentino M, et al: Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Safety. 2002, 11: 149-157. 10.1002/pds.682.CrossRef Leoni O, Martignoni E, Cosentino M, et al: Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Safety. 2002, 11: 149-157. 10.1002/pds.682.CrossRef
15.
go back to reference Le Pen C, Wait S, Moutard-Martin F, et al: Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics. 1999, 16: 59-69.CrossRef Le Pen C, Wait S, Moutard-Martin F, et al: Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics. 1999, 16: 59-69.CrossRef
16.
go back to reference Hughes AJ, Daniel SE, Kilford L, et al: The accuracy of the clinical diagnosis of Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184.CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, et al: The accuracy of the clinical diagnosis of Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Anonymous: International Classification of Diseases. 1997, Geneva: WHO, 9 Anonymous: International Classification of Diseases. 1997, Geneva: WHO, 9
19.
go back to reference Anonymous: Guidelines for ATC Classification. 1993, Oslo: WHO Collaborating Centre for Drug Statistics Methodology and Nordic Council on Medicines Anonymous: Guidelines for ATC Classification. 1993, Oslo: WHO Collaborating Centre for Drug Statistics Methodology and Nordic Council on Medicines
20.
go back to reference Ziegler M, Levy E: A cost analysis of the treatment of Parkinson disease. Ann Psychiatr. 1990, 5: 348-353. Ziegler M, Levy E: A cost analysis of the treatment of Parkinson disease. Ann Psychiatr. 1990, 5: 348-353.
21.
go back to reference Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL: The health burdens of Parkinson's disease. Mov Disord. 1998, 13: 406-413.CrossRefPubMed Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL: The health burdens of Parkinson's disease. Mov Disord. 1998, 13: 406-413.CrossRefPubMed
22.
go back to reference Dodel RC, Singer M, Köhne-Volland R, et al: The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. Pharmacoeconomics. 1998, 14: 299-312.CrossRefPubMed Dodel RC, Singer M, Köhne-Volland R, et al: The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. Pharmacoeconomics. 1998, 14: 299-312.CrossRefPubMed
23.
go back to reference Wood BH, Bilclough JA, Bowron A, Walker RW: Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002, 72: 721-725. 10.1136/jnnp.72.6.721.CrossRefPubMedPubMedCentral Wood BH, Bilclough JA, Bowron A, Walker RW: Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002, 72: 721-725. 10.1136/jnnp.72.6.721.CrossRefPubMedPubMedCentral
24.
go back to reference Diederich NJ, Moore CG, Leurgans SE, et al: Parkinson disease with old-age onset. A comparative study with subjects with middle-age onset. Arch Neurol. 2003, 60: 529-533. 10.1001/archneur.60.4.529.CrossRefPubMed Diederich NJ, Moore CG, Leurgans SE, et al: Parkinson disease with old-age onset. A comparative study with subjects with middle-age onset. Arch Neurol. 2003, 60: 529-533. 10.1001/archneur.60.4.529.CrossRefPubMed
25.
go back to reference Schrag A, Hovris A, Morley D, et al: Young versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord. 2003, 18: 1250-1256. 10.1002/mds.10527.CrossRefPubMed Schrag A, Hovris A, Morley D, et al: Young versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord. 2003, 18: 1250-1256. 10.1002/mds.10527.CrossRefPubMed
26.
go back to reference Kennerfalk A, Ruigòmez A, Wallander MA, et al: Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother. 2002, 36: 797-803. 10.1345/aph.1A226.CrossRefPubMed Kennerfalk A, Ruigòmez A, Wallander MA, et al: Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother. 2002, 36: 797-803. 10.1345/aph.1A226.CrossRefPubMed
27.
go back to reference Fernandez HH, Lapane KL, Ott BR, Friedman JH: Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. Mov Disord. 2000, 15: 490-496. 10.1002/1531-8257(200005)15:3<490::AID-MDS1011>3.0.CO;2-E.CrossRefPubMed Fernandez HH, Lapane KL, Ott BR, Friedman JH: Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. Mov Disord. 2000, 15: 490-496. 10.1002/1531-8257(200005)15:3<490::AID-MDS1011>3.0.CO;2-E.CrossRefPubMed
28.
go back to reference Zeiewicz TA, Hauser RA: Depression in Parkinson's disease. Curr Psychiatry Rep. 2002, 4: 69-73.CrossRef Zeiewicz TA, Hauser RA: Depression in Parkinson's disease. Curr Psychiatry Rep. 2002, 4: 69-73.CrossRef
29.
go back to reference Lemack GE, Dewey RB, Roehrborn CG, et al: Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology. 2000, 56: 250-254. 10.1016/S0090-4295(00)00641-5.CrossRefPubMed Lemack GE, Dewey RB, Roehrborn CG, et al: Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology. 2000, 56: 250-254. 10.1016/S0090-4295(00)00641-5.CrossRefPubMed
30.
go back to reference Clarke CE, Guttmann M: Dopamine agonist monotherapy in Parkinson's disease. Lancet. 2002, 360: 1767-1769. 10.1016/S0140-6736(02)11668-0.CrossRefPubMed Clarke CE, Guttmann M: Dopamine agonist monotherapy in Parkinson's disease. Lancet. 2002, 360: 1767-1769. 10.1016/S0140-6736(02)11668-0.CrossRefPubMed
31.
go back to reference Reichmann H: Long-term treatment with dopamine agonists in idiopathic Parkinson's disease. J Neurol. 2000, 247 (suppl 4): IV/17-IV/19. Reichmann H: Long-term treatment with dopamine agonists in idiopathic Parkinson's disease. J Neurol. 2000, 247 (suppl 4): IV/17-IV/19.
Metadata
Title
Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy
Authors
Marco Cosentino
Emilia Martignoni
Donatella Michielotto
Daniela Calandrella
Giulio Riboldazzi
Claudio Pacchetti
Gianmario Frigo
Giuseppe Nappi
Sergio Lecchini
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2005
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-5-26

Other articles of this Issue 1/2005

BMC Health Services Research 1/2005 Go to the issue